multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-26 18:56 (3302 d 06:35 ago) – Posting: # 15858
Views: 4,088

❝ Please share your thoughts on that.


I've done a few of those IR/XR or IR/ER bilayer tablets before and emesis was be based on IR. It's one tablet for administration. Why would you based on MR for emesis dropout criteria?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
228 visitors (0 registered, 228 guests [including 19 identified bots]).
Forum time: 01:32 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5